Arena Pharmaceuticals ARNA

Annual report 2021
added 12-16-2023

Arena Pharmaceuticals DIO Ratio 2011-2026 | ARNA

Annual DIO Ratio Arena Pharmaceuticals

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	160	263	510	754	602	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
754	160	458

DIO Ratio of other stocks in the Biotechnology industry

	Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
	Acorda Therapeutics ACOR	345	-	-24.86 %	$ 820 K	USA
	BioXcel Therapeutics BTAI	227	$ 1.82	0.55 %	$ 4.61 M	USA
	Aeterna Zentaris AEZS	55.6	-	5.93 %	$ 314 M	Canada
	Alexion Pharmaceuticals, Inc. ALXN	512	-	-	$ 40.3 B	USA
	Amphastar Pharmaceuticals AMPH	132	$ 25.88	-1.01 %	$ 1.25 B	USA
	Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
	Corcept Therapeutics Incorporated CORT	338	$ 43.14	4.46 %	$ 4.45 B	USA
	Catalyst Pharmaceuticals CPRX	93.3	$ 23.9	-2.27 %	$ 2.83 B	USA
	Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
	Aytu BioScience AYTU	209	$ 2.72	0.18 %	$ 17.1 M	USA
	Acasti Pharma ACST	136	-	4.01 %	$ 150 M	Canada
	BeiGene, Ltd. BGNE	304	-	0.49 %	$ 251 B	Cayman-islands
	Albireo Pharma ALBO	26.1	-	-0.23 %	$ 916 M	USA
	Coherus BioSciences CHRS	116	$ 2.05	28.93 %	$ 193 M	USA
	Biogen BIIB	394	$ 171.06	-1.58 %	$ 24.9 B	USA
	Baudax Bio BXRX	596	-	0.59 %	$ 63 K	USA